SCHEMBL4637375

SCHEMBL4637375

C#CC(C)n1c(C#Cc2cccc(OC)c2)nc2c1c(=O)[nH]c(=O)n2CCCO

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.41
ADORA2B P29275 1/20 0.41
ADORA1 P30542 1/20 0.41
MEN1 O00255 8/20 0.40
KMT2A Q03164 8/20 0.40
KDM4E B2RXH2 5/20 0.38
ALDH1A1 P00352 5/20 0.38
NPSR1 Q6W5P4 2/20 0.37
LMNA P02545 2/20 0.37
GAA P10253 2/20 0.37
HPGD P15428 2/20 0.37
CYP2C9 P11712 1/20 0.37
ADORA3 P0DMS8 2/20 0.37
MAPT P10636 2/20 0.36
ALOX12 P18054 1/20 0.36
MAPK1 P28482 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
HTT P42858 1/20 0.36
POLB P06746 1/20 0.36
GRM5 P41594 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL3949992 0.77 ADORA2A (0.54) ADORA2AADORA2BADORA1MEN1KMT2A
SCHEMBL4637377 0.77 HPGD (0.40) ADORA2AADORA2BADORA1MEN1KMT2A
SCHEMBL2540252 0.74 ADORA1 (0.67) ADORA2AADORA2BADORA1ADORA3
SCHEMBL3949167 0.74 ADORA2A (0.53) ADORA2AADORA2BADORA1MEN1KMT2A
SCHEMBL4636110 0.73 ADORA3 (0.35) ADORA2BMEN1KMT2AKDM4EALDH1A1
SCHEMBL4636260 0.69 HPGD (0.34) ADORA2BADORA1KMT2AKDM4EALDH1A1
SCHEMBL2541029 0.69 ADORA1 (0.59) ADORA2AADORA2BADORA1ADORA3
SCHEMBL2537944 0.66 ADORA1 (0.44) ADORA2AADORA2BADORA1ADORA3GRM5
SCHEMBL4725744 0.66 ADORA1 (0.53) ADORA2AADORA2BADORA1
SCHEMBL2539378 0.66 ADORA1 (0.56) ADORA2AADORA2BADORA1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1939197-A1 8-ethinylxanthine derivatives as selective A2A receptor antagonists SCHWARZ PHARMA AG (DE) 2008-07-02 EP disclosed